SCHEMBL4151901

SCHEMBL4151901

O=C(c1ccc(O)cc1O)N1CCC(CCc2ccccc2)C1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SPR P35270 2/20 0.62
GRIN2D O15399 5/20 0.55
GRIN3B O60391 5/20 0.55
GRIN1 Q05586 5/20 0.55
GRIN2A Q12879 5/20 0.55
GRIN2B Q13224 5/20 0.55
GRIN2C Q14957 5/20 0.55
GRIN3A Q8TCU5 5/20 0.55
HSP90AA1 P07900 2/20 0.49
HSP90AB1 P08238 2/20 0.49
PDK1 Q15118 1/20 0.47
CTSL P07711 1/20 0.44
CTSB P07858 1/20 0.44
CTSS P25774 1/20 0.44
CTSK P43235 1/20 0.44
CTSC P53634 1/20 0.44
CYP2C9 P11712 3/20 0.44
CYP2C19 P33261 3/20 0.44
MAPK14 Q16539 3/20 0.44
HTR2B P41595 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4145949 0.93 GRIN2D (0.63) SPRGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL4151317 0.88 SPR (0.60) SPRGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL9785745 0.83 CYP2C9 (0.63) SPRGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL4155107 0.81 HSP90AA1 (0.50) SPRHSP90AA1HSP90AB1PDK1
SCHEMBL4151385 0.81 GRIN2D (0.50) SPRGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL1581847 0.78 SPR (0.59) SPRGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL4146438 0.78 GRIN2D (0.47) SPRGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL4147764 0.77 HSP90AA1 (0.48) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL4151865 0.77 HTR2A (0.46) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL4143175 0.77 HSP90AA1 (0.62) SPRHSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS PFIZER, INC. 2009-08-27 US claimed
EP-1879863-A1 AMIDE RESORCINOL COMPOUNDS Pfizer, Inc. (US) 2008-01-23 EP claimed
WO-2006117669-A1 AMIDE RESORCINOL COMPOUNDS PFIZER INC. (US) 2006-11-09 WO claimed
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS PFIZER, INC. 2009-08-27 US disclosed
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS PFIZER, INC. 2009-08-27 US disclosed
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS PFIZER, INC. 2009-08-27 US disclosed
EP-1879863-A1 AMIDE RESORCINOL COMPOUNDS Pfizer, Inc. (US) 2008-01-23 EP disclosed
WO-2006117669-A1 AMIDE RESORCINOL COMPOUNDS PFIZER INC. (US) 2006-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS HSP90AB1, HSP90AA1, HSP90AB2P SPR 906/4885GRIN2D 4403/4885GRIN3B 4418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.